Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Zimmerman

Showing results (121-130 of 393) with videos related to

Pageof 40
Sort By:
The American Journal of Psychiatry|October 7, 2004
Using a self-report depression scale to identify remission in depressed outpatientsMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Clinical Psychopharmacology|March 2, 2005
Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression?Mark Zimmerman, Michael A Posternak, Iwona Chelminski
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|November 27, 2013
Which facets of mindfulness predict the presence of substance use disorders in an outpatient psychiatric sample?Michael E Levin, Kristy Dalrymple, Mark Zimmerman
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 29, 2020
Re-examining borderline personality disorder and substance use disorder: The role of emotion dysregulationMiranda Bethanie Snow, Caroline Balling, Mark Zimmerman
Journal of Affective Disorders|December 15, 2022
Telehealth treatment of patients with major depressive disorder during the COVID-19 pandemic: Comparative safety, patient satisfaction, and effectiveness to prepandemic in-person treatmentMark Zimmerman, Catherine D'Avanzato, Brittany T King
The American Journal of Psychiatry|July 5, 2005
Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trialMark Zimmerman, Iwona Chelminski, Michael A Posternak
Journal of Personality Disorders|April 9, 2024
Recognizing Borderline Personality Disorder in Men: Gender Differences in BPD Symptom PresentationSaivone N Sanchious, Mark Zimmerman, Shereen Khoo
Journal of Abnormal Psychology|October 6, 2010
Challenges associated with a polythetic diagnostic system: criteria combinations in the personality disordersLuke D Cooper, Steve Balsis, Mark Zimmerman
Essential Psychopharmacology|December 23, 2004
Generalizability of antidepressant efficacy trialsMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Traumatic Stress|October 31, 2003
The clinical relevance of a partial remission specifier for posttraumatic stress disorderDawn M Johnson, Caron Zlotnick, Mark Zimmerman
Pageof 40

Showing results (121-130 of 393) with videos related to

Sort By:
Pageof 40
The American Journal of Psychiatry|October 7, 2004
Using a self-report depression scale to identify remission in depressed outpatientsMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Clinical Psychopharmacology|March 2, 2005
Is it time to replace the Hamilton Depression Rating Scale as the primary outcome measure in treatment studies of depression?Mark Zimmerman, Michael A Posternak, Iwona Chelminski
Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors|November 27, 2013
Which facets of mindfulness predict the presence of substance use disorders in an outpatient psychiatric sample?Michael E Levin, Kristy Dalrymple, Mark Zimmerman
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|April 29, 2020
Re-examining borderline personality disorder and substance use disorder: The role of emotion dysregulationMiranda Bethanie Snow, Caroline Balling, Mark Zimmerman
Journal of Affective Disorders|December 15, 2022
Telehealth treatment of patients with major depressive disorder during the COVID-19 pandemic: Comparative safety, patient satisfaction, and effectiveness to prepandemic in-person treatmentMark Zimmerman, Catherine D'Avanzato, Brittany T King
The American Journal of Psychiatry|July 5, 2005
Generalizability of antidepressant efficacy trials: differences between depressed psychiatric outpatients who would or would not qualify for an efficacy trialMark Zimmerman, Iwona Chelminski, Michael A Posternak
Journal of Personality Disorders|April 9, 2024
Recognizing Borderline Personality Disorder in Men: Gender Differences in BPD Symptom PresentationSaivone N Sanchious, Mark Zimmerman, Shereen Khoo
Journal of Abnormal Psychology|October 6, 2010
Challenges associated with a polythetic diagnostic system: criteria combinations in the personality disordersLuke D Cooper, Steve Balsis, Mark Zimmerman
Essential Psychopharmacology|December 23, 2004
Generalizability of antidepressant efficacy trialsMark Zimmerman, Michael A Posternak, Iwona Chelminski
Journal of Traumatic Stress|October 31, 2003
The clinical relevance of a partial remission specifier for posttraumatic stress disorderDawn M Johnson, Caron Zlotnick, Mark Zimmerman
Pageof 40